Brief: Antengene Corp Says On October 29, U.S. FDA Approved Investigational New Drug Application For Atg-101
01/11/2021 01:47
Nov 1 (Reuters) - Antengene Corporation Ltd 6996.HK :
* ON OCTOBER 29, U.S. FOOD AND DRUG ADMINISTRATION APPROVED
INVESTIGATIONAL NEW DRUG APPLICATION FOR ATG-101
Source text for Eikon: ID:nHKS8zBNXT
Further company coverage: 6996.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106